Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G, and ...
Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.
A Canadian research team is examining the use of pramlintide in conjunction with insulin on the artificial-pancreas platform, with the goal of further improving blood glucose management for type 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results